http://articles.mercola.com/sites/articles/archive/2006/10/19/new-cancer-drug-costs-more-than-4200-per-dose.aspxAbraxane, a new version of an old cancer drug, has made millions for the company that manufactures it. It doesn't help patients live any longer than the old treatment. It does, however, cost $4,200 a dose. Roughly 20,000 people have been treated withenCommunityServer 2008.5 SP1 (Build: 31106.3070)